
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An African-Specific Variant ofTP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression
Alexandra Indeglia, Jessica C. Leung, Sven A. Miller, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1696-1719
Open Access | Times Cited: 12
Alexandra Indeglia, Jessica C. Leung, Sven A. Miller, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1696-1719
Open Access | Times Cited: 12
Showing 12 citing articles:
Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression
Alexandra Indeglia, Maureen E. Murphy
Critical Reviews in Biochemistry and Molecular Biology (2024) Vol. 59, Iss. 1-2, pp. 128-138
Open Access | Times Cited: 7
Alexandra Indeglia, Maureen E. Murphy
Critical Reviews in Biochemistry and Molecular Biology (2024) Vol. 59, Iss. 1-2, pp. 128-138
Open Access | Times Cited: 7
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression
Yaxuan Zhou, Rinka Nakajima, Mashiro Shirasawa, et al.
Biology (2023) Vol. 12, Iss. 12, pp. 1511-1511
Open Access | Times Cited: 12
Yaxuan Zhou, Rinka Nakajima, Mashiro Shirasawa, et al.
Biology (2023) Vol. 12, Iss. 12, pp. 1511-1511
Open Access | Times Cited: 12
Harnessing p53 for targeted cancer therapy: new advances and future directions
Zdeněk Andrysík, Joaquı́n M. Espinosa
Transcription (2025), pp. 1-44
Open Access
Zdeněk Andrysík, Joaquı́n M. Espinosa
Transcription (2025), pp. 1-44
Open Access
Emerging insights into ethnic-specific TP53 germline variants
Nicholas W. Fischer, Yu‐Heng Vivian, Jean Gariépy
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 10, pp. 1145-1156
Open Access | Times Cited: 7
Nicholas W. Fischer, Yu‐Heng Vivian, Jean Gariépy
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 10, pp. 1145-1156
Open Access | Times Cited: 7
Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent
Arnold J. Levine, John D. Carpten, Maureen E. Murphy, et al.
Cell Death and Differentiation (2023)
Open Access | Times Cited: 4
Arnold J. Levine, John D. Carpten, Maureen E. Murphy, et al.
Cell Death and Differentiation (2023)
Open Access | Times Cited: 4
Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of the Li-Fraumeni Syndrome.
Emilie Montellier, Nicolas Lemonnier, Judith Penkert, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111296-111296
Closed Access | Times Cited: 1
Emilie Montellier, Nicolas Lemonnier, Judith Penkert, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111296-111296
Closed Access | Times Cited: 1
Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide
Tonia Carter, Robert K. Valenzuela, Srinivasulu Yerukala Sathipati, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
Tonia Carter, Robert K. Valenzuela, Srinivasulu Yerukala Sathipati, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network
Anthony M. Boutelle, Aicha R. Mabene, David Yao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Anthony M. Boutelle, Aicha R. Mabene, David Yao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
The mechanism of quercetin in treating intracerebral hemorrhage was investigated by network pharmacology and molecular docking
Ziyou Zhang, Xiaoyu Lv, Xinpei Zhou, et al.
Medicine (2024) Vol. 103, Iss. 40, pp. e40010-e40010
Open Access
Ziyou Zhang, Xiaoyu Lv, Xinpei Zhou, et al.
Medicine (2024) Vol. 103, Iss. 40, pp. e40010-e40010
Open Access
Genome-Wide Analysis of p53 Targets Reveals SCN2A as a Novel Player in p53-Induced Cell Arrest in HPV-Positive Cells
Yudi Zhang, Yi Liu, Xue-Yan Xing, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1725-1725
Open Access
Yudi Zhang, Yi Liu, Xue-Yan Xing, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1725-1725
Open Access
Fine resolution clustering ofTP53variants into functional classes predicts cancer risks and spectra among germline variant carriers
Emilie Montellier, Nathanaël Lemonnier, Judith Penkert, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Emilie Montellier, Nathanaël Lemonnier, Judith Penkert, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Identifying p53 Target Genes Using Hypomorphic Variants
Bibek Bhatta, Tomer Cooks
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1518-1520
Closed Access
Bibek Bhatta, Tomer Cooks
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1518-1520
Closed Access